Sabby Management’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Sabby Management’s Portfolio OPXAW Stock Details OPXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-34,097	Closed	-$2K	–	370
2016 Q1	$2K	Buy	+34,097	New	+$2.42K	﹤0.01%	294
2015 Q4	–	Sell	-382,765	Closed	-$46K	–	410
2015 Q3	$46K	Sell	382,765 -162,740	-30%	-$19.8K	﹤0.01%	374
2015 Q2	$93K	Buy	+545,505	New	+$81.6K	﹤0.01%	308

Other funds holding OPXAW

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Sabby Management's OPXAW Position: Q2 2016 in Review

Sabby Management sold out of Opexa Therapeutics, Inc. (OPXAW) in Q2 2016, closing a stake of 34,097 shares — an estimated $2K sold.

Sabby Management first reported a position in OPXAW in Q2 2015 and held it in 3 quarters. The position peaked at $93K in Q2 2015. 4 funds tracked by Wall St. Rank hold OPXAW as of Q2 2016.

Sabby Management reported no remaining Opexa Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Sabby Management sold 34,097 Opexa Therapeutics, Inc. shares in Q2 2016, an estimated $2K.
Sabby Management first reported a position in Opexa Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
Sabby Management's Opexa Therapeutics, Inc. position peaked at $93K in Q2 2015.
4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q2 2016.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.